Biosensors Market Predicts Point of Care Testing Segment to

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
382
Biosensors Market Predicts Point of Care Testing Segment to Dominate Future Demand - Market Intel Reports

Delaware, March 08, 2017 (GLOBE NEWSWIRE) -- The report “ Biosensors Market: By Product (Wearable, & Non-Wearable Biosensors), By Technology (Electrochemical, Piezoelectric, Optical, Thermal, & Other Biosensors), By Application, By End-User, & By Region-Forecast 2021 ”, available on MarketIntelReports, estimates that the Asia-Pacific market will register highest growth of demand during the forecast period.

 

Browse numerous Market Tables as well as Figures which are spread through 149 Pages and an in-depth TOC on the “ Biosensors Market 2021 http://www.marketintelreports.com/report/hcr0...t-20142021

 

Scope & Regional Forecast of the Biosensors Market

 

Biosensors can be described as analytical devices which are primarily used for detecting analytes. Whenever biological elements like tissues or enzymes interact with the analyte, a specialized signal is emitted. Biosensors and bioelectronics are used to convert the signal in such a way that it can be analyzed or measured in an easy manner. Bio electronics help in displaying the quantified signal in a meaningful method. A sensor can be customized and manufactured so that it can fit a variety of biosensor principles. Thus, the Biosensors Market is well placed to exhibit significant expansion during the forecast period of 2014-2021.

 

Request Sample PDF Brochure @ http://www.marketintelreports.com/pdfdownload.php?id=hcr0160

 

The Biosensors Market considers the primary growth drivers to be a few factors like: technical advances made in field of nanotechnology; rising demand for point-of-care devices like wearable biosensors; requirement for constant glucose monitoring through biosensor technology  in patients suffering from diabetes; and the widening of biosensors applications to include non-medical segments like food and biodefense. Biosensor companies are also expected to pump in more money into cutting-edge R&D efforts whose aim is to bring down costs and develop a system for global standardization.

 

Currently, the Biosensors Market is dominated by demand emanating from North America owing to its superior healthcare infrastructure and relatively better medical insurance coverage in the form of Obamacare. On the other hand, Asia-Pacific is expected to register the fastest demand growth during the forecast period of 2014-2021. The rapid pace of this growth is expected due to developments like rapidly aging population in countries like Japan, and consistent government investments and initiatives to overhaul the healthcare infrastructure in the region. Biosensor companies have also witnessed that the demand for point of care testing currently holds the largest market share.

 

Inquiry before buying report @ http://www.marketintelreports.com/inquiry-bef...id=hcr0160

 

Segmentations & Key Players Involved in the Biosensors Market

The Biosensors Market can be broken down into various segmentations on the basis of -

 

  • Product : Wearable Biosensors and Non-Wearable Biosensors.
  • Technology : Electrochemical Biosensors, Piezoelectric Biosensors, Optical Biosensors, Thermal Biosensors and Others.
  • Application : Medical, Food Toxicity Detection, Industrial Process Control, Agriculture, Environment and Others.
  • End-User : Point-of-Care, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring, Food Industry and Others.
  • Geographical Location : Europe, Asia-Pacific, North America and Rest of the World.

 

Some of the key players involved in the Biosensors Market are as follows :

  • Lifescan, INC.
  • Medtronic INC.
  • Nova Biomedical Corporation
  • Universal Biosensors
  • Pharmaco-Kinesis Corporation
  • Siemens AG
  • Universal Biosensors
  • Acon Laboratories, INC.

 

  Why buy this report?

  • Get a detailed picture of the Biosensors Market.
  • Pinpoint growth sectors and identify factors driving change.
  • Understand the competitive environment, the market’s major players and leading brands.
  • A five-year forecast method is used in order to assess how the market is predicted to develop.

 

Purchase Biosensors Market @ http://www.marketintelreports.com/purchase.php?id=hcr0160

 

About Us:

MarketIntelReports (MIR) aims to empower our clients to successfully manage and outperform in their business decisions. We do this by providing Premium Market Intelligence, Strategic Insights and Databases from a range of Global Publishers.

 

MarketIntelReports currently has more than 150,000 plus titles and 100+ publishers on our platform and growing consistently to fill the “Global Intelligence Demand – Supply Gap”. We cover more than 15 industry verticals being: Automotive, Electronics, Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Building & Construction, Agriculture, Food & Beverages, Banking & Finance, Media and Government, Public Sector Studies.

 

Media Contact

Company Name: Market Intel Reports

Contact Person: Mayur S

Email: sales@marketintelreports.com

Phone: 1-302-261-5343

Address: 2712 Centerville Road, Suite 400

City: Wilmington

State: Delaware

Country: United States

 

 

 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 5

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 5

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 8

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading

Top 5 Most Recently Viewed Articles

In-Silico Clinical Trials Expected to Surge to $6.39 Billion

Updated Category News Views 196

In-Silico Clinical Trials Market Overview The in-silico clinical trials market is witnessing substantial growth, projected to reach USD 6.39 billion in the near future. This transformation reflects a significant shift in how pharmaceutical and medical technology companies approach drug development and clinical evaluation. By leveraging advanced digital technologies,...

Continue Reading
Longeveron Inc. Announces Significant Leadership Changes

Updated Category News Views 162

Longeveron Inc. Leadership Evolution Longeveron Inc. has recently made pivotal updates to its leadership team, signaling significant strategic shifts within the company. Than Powell is stepping up as the Interim CEO, while Dr. Joshua Hare, a cornerstone of the company, takes on the role of Executive Chairman of the Board. These changes come as the company aims to enhance...

Continue Reading
Aebi Schmidt Group's Growth Strategy Post-Merger Unveiled

Updated Category News Views 218

Aebi Schmidt Group's Strategic Vision After Merger Aebi Schmidt Group is actively trading under the ticker symbol "AEBI" after completing an exciting merger with The Shyft Group. The organization is well-positioned with a robust balance sheet, focusing on executing its post-merger strategies effectively. Amidst a dynamic operating environment, the company's commitment to...

Continue Reading
Unibail-Rodamco-Westfield Achieves Top ‘A’ Rating in Sustainability

Updated Category News Views 373

Unibail-Rodamco-Westfield's Commitment to Sustainability Unibail-Rodamco-Westfield, often abbreviated as URW, has accomplished an impressive feat by receiving a top ‘A’ rating from CDP for the seventh consecutive year. This recognition is a testament to the company's continuous efforts and transparent actions in combating climate change, all structured under its...

Continue Reading
Genstar Capital Hires Industry Veteran John Kufner for Advisory

Updated Category News Views 280

Big Moves in Private Equity: Genstar's New Addition What’s the deal here? Genstar Capital, that powerhouse in private equity, just scored big by bringing John Kufner on board as part of their Strategic Advisory Board. This isn’t just another hire; it's a strategic chess move. Kufner isn’t your run-of-the-mill executive—he's been around the block more than a few...

Continue Reading